Proton pump inhibitor (PPI) medications such as these have been proven effective at getting rid of heartburn while simultaneously putting patients at risk of having a heart attack.
Recent studies have shown patients who take PPI’s frequently have a significantly higher risk of having a heart attack and almost double the risk of cardiovascular mortality than those who do not. As these medications become increasingly available over the counter, you should consider whether the risks outweigh the benefits before taking them.
As a result of new findings, researchers from Houston Methodist and Stanford University California warn these drugs may not be as safe as we think since they tend to have a negative impact on patients. PPI medications are used commonly to treat heart burn and acid reflux disease. They are among the world’s most widely prescribed medications, generating $14 billion in annual sales for pharmaceutical manufacturers.
It is important to note the difference between PPI and H2 Blocker medications. Both are used to treat acid reflux and heartburn. However, H2 Blockers such as Zantac and Pepcid block signals in the cells that are responsible for acid secretion and provide temporary relief. PPI’s on the other hand, shut the cells down that maintain acid in the stomach entirely. PPIs are much stronger and typically last up to 24 hours while the effects may last up to three days. H2 Blocker medications have not been linked to causing heart attacks or any other adverse reaction to date.
Though researchers in the Stanford study were unable to show PPI medications undoubtedly cause heart attacks in patients, they are warning the increased risks associated with having a heart attack after taking these medications is profound.
If you or a loved one suffered from a heart attack after taking Prilosec, Prevacid, or Nexium call 1-800-LAW-FIRM immediately. You may be entitled to a cash settlement for your suffering. Call us now for a free consultation.
H2 Blocker medicines have not been linked to high risks of heart attack even though they are used to treat the same symptoms as proton pump inhibitors. H2 Blockers only block signals on the cells that are responsible for acid secretion and provide temporary relief. PPI medicines shut the cells down that maintain acid in the stomach entirely, and stay present in the body much longer. Patients using H2 Blockers to treat their heartburn and acid reflux do not qualify for this litigation.